Toward a Less Expensive Version of the Anti-Flu Drug Tamiflu, Study in Organic Letters

ScienceDaily (Jan. 14, 2010) — Scientists have developed an alternative method for producing the active ingredient in Tamiflu®, the mainstay for fighting H1N1 and other forms of influenza. The new process could expand availability of the drug by reducing its cost, which now retails for as about $8 per dose.

MORE ON THIS TOPIC